Corbenic Partners LLC Bristol Myers Squibb CO Transaction History

Corbenic Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$59.17 - $69.31 $5,976 - $7,000	-101 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $1,238 - $1,348	20 Added 24.69%	101 $7,000
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $4,806 - $5,405	81 New	81 $5,000
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $2,741 - $3,204	-50 Closed	0 $0
Q4 2019 Jan 14, 2020	SELL	$49.21 - $64.19 $36,907 - $48,142	-750 Reduced 93.75%	50 $3,000
Q2 2017 Aug 14, 2017	BUY	N/A	800	800 $45,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Corbenic Partners LLC with notifications on news.